IL1B and Stroke: Moreover, modulation of the IL-1 response with the administration of the naturally occurring interleukin-1 receptor antagonist (IL-1Ra) significantly improved neuroinflammation and neurological outcome in animals with multiple risk factors for stroke, including advanced age [25].